Edward Gane

发表

Diabetes Mellitus Following Liver Transplantation in Patients With Hepatitis C Virus: Risks and Consequences

E. Gane, Edward Gane, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Sofosbuvir and velpatasvir with or without voxilaprevir in direct‐acting antiviral‐naïve chronic hepatitis C: patient‐reported outcomes from POLARIS 2 and 3

T. Asselah, M. Stepanova, L. Henry, 2018, Alimentary pharmacology & therapeutics.

Peginterferon alfa-2a in patients with chronic hepatitis C.

E. Heathcote, J. Rasenack, A. Lin, 2000, The New England journal of medicine.

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use

M. Hellard, G. Dore, P. Bruggmann, 2018 .

Efficacy of nucleotide polymerase inhibitor sofosbuvir plus the NS5A inhibitor ledipasvir or the NS5B non-nucleoside inhibitor GS-9669 against HCV genotype 1 infection.

C. Stedman, P. Pang, E. Gane, 2014, Gastroenterology.

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Tom Chu, Peter W Angus, P. Angus, 2010, The Lancet.

High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis

P. Thuluvath, D. Mutimer, C. Hézode, 2018 .

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection.

John F. Flaherty, G. Foster, K. Agarwal, 2015, Journal of hepatology.

Reimbursement policies in the Asia-Pacific for chronic hepatitis B

Keat Hong Lee, J. Kao, S. Sarin, 2014, Hepatology International.

Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection

G. Cooke, G. Dore, C. Orkin, 2018, Journal of viral hepatitis.

Liver transplantation for haemophiliacs with hepatitis C cirrhosis.

N. Heaton, R. Williams, S. Pereira, 1996, Gut.

Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment‐naïve patients with HBV‐related decompensated cirrhosis

C. Yurdaydın, S. Sarin, G. Choudhuri, 2012, Journal of viral hepatitis.

Efficacy and safety results of patients with HCV genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (QUARTZ II‐III)

T. Pilot‐Matias, G. Foster, K. Agarwal, 2018, Journal of viral hepatitis.